KalshiVerificar disponibilidadeKYC obrigatório2% de taxaDados de resolução verificadosRazoavelmente calibradoProbabilidade implícita atual
BPC-157 79%Líder entre 7 opções
Qualidade do mercado
41 / 100
Baixa qualidadeVolume 24h
—
Liquidez
999,6 €
Baixa liquidezSpread
4.0 pt
Spread moderadoDados do mercado
Atualizado há 5 minutos
28/07/26, 16:30 UTC1/10/27, 03:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Miami-Dade WASD ceases adding fluoride to its drinking water by 2027
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiWhat will Trump say during his announcement on healthcare?
KalshiHeidi Overton confirmed as FDA Commissioner by which date?
PolymarketHantavirus vaccine in 2026?
PolymarketRegras
If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Liquida via:U.S. Food and Drug Administration
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add TB-500 (free base) or TB-500 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add MOTS-c (free base) or MOTS-c acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Semax (free base) or Semax acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
- If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Epitalon (free base) or Epitalon acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.
Mercados abertos
Health & MedicineKALSHIWhat will Trump say during his announcement on healthcare?
- Favored Nation94%
- Pharma / Pharmaceutical86%
- Medicare / Medicaid85%
+23 mais resultados
- Volume total
- € 19,8 mil
- Volume 24h
- € 19,8 mil
POLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Volume total
- € 15,9 mi
- Volume 24h
- € 6,5 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-3.0pt93%
- Above 6000-5.0pt58%
+2 mais resultados
- Volume total
- € 895,9 mil
- Volume 24h
POLYMARKETHantavirus vaccine in 2026?
- No+0.3pt97%
- Yes-0.3pt3%
- Volume total
- € 120,7 mil
- Volume 24h
- € 1,9 mil
POLYMARKETMeasles cases in U.S. in 2026?
- ↑3.5k+0.7pt100%
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
+9 mais resultados
KALSHIWill the FDA approve any psychedelic substance for medical use this year?
- No65%
- Yes+13.0pt35%
- Volume total
- € 337,2 mil
- Volume 24h
- € 1,5 mil
- Heidi Overton confirmed as FDA Commissioner by which date?
- Measles cases in U.S. by September 30?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Which countries will report an Ebola case in 2026?
- Confirmed US Screwworm case in Livestock beyond Texas by...
- When will the FDA approve Compass Pathways' COMP360 Psilocybin?
- Ebola pandemic in 2026?
- Pandemic in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
Perguntas frequentes
- Quais são as probabilidades atuais de Which peptides will the FDA propose adding to the 503A Bulks List??
- A Kalshi cota BPC-157 em 79% em 18 de setembro de 2026.
- Quando Which peptides will the FDA propose adding to the 503A Bulks List? é resolvido?
- Which peptides will the FDA propose adding to the 503A Bulks List? deverá ser resolvido em 1 de outubro de 2027.
- Como Which peptides will the FDA propose adding to the 503A Bulks List? é liquidado?
- A Kalshi liquida este mercado da seguinte forma: If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.